![1-Pyrrolidinecarboxylic acid, 2,2'-([1,1'-biphenyl]-4,4'-diyldi-1H-iMidazole-5,2-diyl)bis-, 1,1'-bis(1,1-diMethylethyl) ester, (2S,2'S)- structure, CAS 1007882-23-6](/structures/180000/168329_2_1007882_23_6.png)
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 1007882-23-6 |
| Catalog No. | 2A-1168279 |
| Chinese Name | 达卡他韦中间体II |
| Synonyms | Daclatasvir intermediate; di-tert-butyl(2S,2'S)-2,2'-(4,4'-biphenyldiylbis(1H-imidazole-5,2-diyl))di(1-pyrrolidinecarboxylate) |
| Molecular Formula | C36H44N6O4 |
| Molecular Weight | 624.772 |
| Density | 1.2±0.1 g/cm3 |
| Boiling Point | 890.2±65.0 °C at 760 mmHg |
| Storage Condition | 2-8°C, dry and sealed |
| Application | HCV-IN-30 (compound 48) is an inhibitor of the HCV NS5A replication complex with IC50s of 901 and 102 nM for HCV type 1a and 1b replication, respectively. |
| PubChem ID | 53782778 |
| SMILES | CC(C)(C)OC(=O)N1CCCC1c1ncc(-c2ccc(-c3ccc(-c4cnc(C5CCCN5C(=O)OC(C)(C)C)[nH]4)cc3)cc2)[nH]1 |
| InChI | InChI=1S/C36H44N6O4/c1-35(2,3)45-33(43)41-19-7-9-29(41)31-37-21-27(39-31)25-15-11-23(12-16-25)24-13-17-26(18-14-24)28-22-38-32(40-28)30-10-8-20-42(30)34(44)46-36(4,5)6/h11-18,21-22,29-30H,7-10,19-20H2,1-6H3,(H,37,39)(H,38,40)/t29-,30-/m0/s1 |
| InChI Key | WPMTYMFNINZZHE-KYJUHHDHSA-N |
| Transport Info | Product name: HCV-IN-30 |
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA